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Phenotypes of inherited nonsyndromic retinal diseases






































































Anatomy of the human eye and retina. (A) 
Cross section showing the major landmarks of 
the human eye and retina. The borders of the 
macula, which is adjacent to the optic disc, are 
indicated with a dashed line. Fundus views of 
patients with (B) normal vision; (C) retinitis 
pigmentosa (pigmentary changes indicated 
by arrowheads); (D) STGD1 due to ABCA4 
mutations; and (E) LCA due to a homozygous 
RPE65 mutation. +, fovea; od, optic disc; INL 
inner nuclear layer; ONL, outer nuclear layer.
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Schematic representation of three major pro-
cesses in human rod photoreceptor cells and 
the RPE. Upper panel: The retinoid cycle tak-
ing place in rod photoreceptor cells (PC) and 
the RPE. Upon photactivation, 11-cis-retinal is 
converted into all-trans-retinal and dissociates 
from activated rhodopsin. The all-trans-retinal 
is then recycled to produce more 11-cis-reti-
nal via several enzymatic steps in the RPE. 
ABCA4 mediates transport of all-trans-reti-
nal to the outside of the photoreceptor outer 
segment disks. The localization and function 
of proteins involved in AR and XL nonsyn-
dromic retinal dystrophies are depicted, with 
the exception of GCAP, a critical Ca2+-bind-
ing interactor of GUCY2D, which is mutated in 
autosomal dominant CRD (http://www.sph.uth.
tmc.edu/Retnet/home.htm). CRALBP, protein 
product of RLBP1; IRBP, protein product of 
RBP3; RAL, retinal; RE, retinyl esters; RHOa, 
photoactivated rhodopsin; ROL, retinol. Mid-
dle panel: The phototransduction cascade in 
rod PCs. Upon photoactivation, amplification 
of the signal is mediated through the α-subunit 
of transducin and phosphodiesterase, which 
results in closure of the cGMP-gated channel, 
hyperpolarization of the cell, and reduced glu-
tamate release at the synapse. SAG, arrestin. 
Lower panel: Ciliary transport along the con-
necting cilium. Kinesin II family motors medi-
ate transport toward the outer segments; cyto-
plasmic dynein 2/1b (DYNC2H1) is involved in 
transport processes from the outer segments 
toward the inner segments. The precise roles 
of CEP290, Lebercilin, RPGR, RPGRIP1, and 
RP1 in ciliary transport processes are not yet 
known. AIPL1 (not indicated in this figure) is a 
chaperone for proteins that are farnesylated. 
For IDH3B and PRCD, the exact cellular func-
tions are not known. ADAM9, MERTK, and 
RGR are secreted by the RPE and localize in 
the interphotoreceptor matrix. The CNGA3, 
CNGB3, GNAT2, and PDE6C genes are spe-
cifically expressed in cone PCs and therefore 
not indicated in this figure. At the right side, a 
Müller cell (MC) connects to the photorecep-
tor cell with the transmembrane protein CRB1. 
Usherin, protein product of USH2A.
review series
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 120      Number 9      September 2010  3045
Table 1
Nonsyndromic recessive retinal dystrophy genes, their associated human phenotypes, animal models, and gene therapy studies
Human  Recessive  Cellular  Mouse  Other recessive  Gene OMIM no. OMIM no. Gene Gene 
gene phenotypes  expression in  model  animal models refs. (gene) (disease)  therapy  therapy
  the retina (variant)  (variantA)    model refs.
ABCA4 STGD1,  Cones and rods  KO No 73 601691 248200,  Mouse 40, 49
 CRD, RP      604116, 601718
ADAM9 CRD RPE KO No 74 602713 612775 No 
AIPL1 LCA Rods KO, KD No 75–77 604392 604393 Mouse 32, 72
CACNA2D4 CD Unknown C57BL/10  No 78 608171 610478 No 
   (c.2367insC)
CEP290 LCA, RP Cones and rods rd16  Cat  79, 80 610142 611755 No 
   (∆ex35–39) (c.6960+9T→G)
CERKL CRD, RP Cones and rods KO No 81 608381 608630, 268000 No 
CNGA1 RP Rods NoB No  123825 612095 No 
CNGA3 ACHM, CD Cones KO No 82 216900 268000 No 
CNGB1 RP Rods KO No 83, 84 600724 600724 No 
CNGB3 ACHM, CRD Cones KO Dog 85, 86 605080 262300 Mouse 87
CRB1 LCA, RP Müller cells KO, KI  No 88–90 604210 600105 No 
   (p.C249W), rd8
CRX LCA Cones and rods,  KO No 91 602225 120970, 268000 No 
  bipolar cells
EYS RP, CRD Cones and rods No mouse  No  612424 602772 No 
   ortholog
GNAT2 ACHM Cones Cpfl3 (p.D200N) No 92 139340 139340 Mouse 93
GUCY2D LCA Cones and rods KO rd chicken  94, 95 600179 204000 Mouse 23, 96
    (Δex4–7)
IDH3B RP Unknown No No 97, 98 604526 612572 No 
KCNV2 CD  Cones and rods No No 99–101 607604 610024 No 
LCA5 LCA Cones and rods NoB No 102 611408 604537 No 
LRAT LCA, RP RPE KO No 103 604863 613341 Mouse 104
MERTK LCA, RP RPE KO RCS rat 105 604705 604705 Rat 106, 107
NR2E3 RP, ESCS Rods KO, rd7 No 108 604485 268100,  No 
       604485, 611131
NRL RP Rods KO No 109 162080 162080 No 
PDE6A RP Rods Chemically induced rcd3 dog 104, 110 180071 180071 No 
PDE6B RP Rods rd1, rd10 Dog 111, 112 180072 180072 Mouse 41, 56, 
         113–116
PDE6C ACHM, CD Cones cpfl1 No 117–119 600827 600827, 613093 No 
PRCD RP Cones and rods,  No Dog 120, 121 610598 610599 No 
  RPE, GCL
PROM1 RP Cones and rods KO No 122 604365 612095 No 
RBP3 RP Cones, rods,  KO No 123, 124 180290 NA No 
  RPE, Müller
RD3 LCA Cones and rods rd3 No  180040 610612 No 
RDH12 LCA Rods KO No 125–128 608830 612712 No 
RDH5 CD RPE KO No 129, 130 601617 601617 No 
RGR RP RPE KO No 131, 132 600342 600342 No 
RHO RP Rods KI, KO No  180380 180380, 184380 Mouse 133
RLBP1 RP, RPA RPE, Müller KO No  180090 1800990, 607476 No 
RP1 RP Cones and rods KO No 134, 135 603937 180100 No 
RP2 XL RP Ubiquitous NoB No 136, 137 300757 312600 No 
RPE65 LCA, RP RPE KO, KI (p.R91W),  Dog 97, 98 180069 204100 Mouse,  34, 36, 
   rd12     dog  57, 138–140
RPGR XL RP, XL CRD Cones and rods KO XLPRA1,  99–101 312610 300029,  No 
    A2 dogs   304020, 300455
RPGRIP1 LCA, CRD Cones and rods KO Dog 102 605446 605446, 608194 Mouse 141
SAG RP Rods NoB No 103 181031 181031 No 
SPATA7 LCA, RP GCL, INL, PR NoB No 105 609868 609868, 604232 No 
TULP1 LCA, RP Cones and rods KO No 108 602280 602280 No 
USH2A RP, USH2 Cones and rods,  KO, RBF/DnJ No 109 608400 608400 No
  OPL
 AVariants listed only if they are not null alleles. BES cells available at EUCOMM (http://www.eucomm.org/) or KOMP (http://www.komp.org).OMIM: http://
www.ncbi.nlm.nih.gov/omim; ECSC, enhanced S syndrome; KD, knockdown; KI, knock-in; NA, not available.
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Animal models for recessive retinal dystrophies
Mouse models. Rodent models of retinal dystrophy have been very 
useful for proof of concept of gene therapy studies, in part because 
















Phenotypic overlap among autosomal recessive retinal dystrophies. 
Patients with ACHM display a virtually stationary cone defect in which 
cones are principally defective. At end stage, CD can hardly be distin-
guished from CRD. Patients with STGD1 later in life show mid-periph-
eral defects similar to those in CRD patients. Patients with RP initially 
display tunnel vision due to rod defects that very often progresses to 
complete blindness when the cones are also affected. In patients with 
LCA, the defects can occur in both types of photoreceptors, or in RPE 
cells, and therefore clinical and molecular genetic overlap with CD, 
CRD, or RP can be expected.
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Prevalence of mutations in genes causing genetically heterogeneous 
retinal dystrophies. Estimated prevalence of mutations in genes caus-
ing AR RP, LCA, AR CRD, AR CD, and ACHM. Mutations in approxi-
mately 50% of AR RP, 30% of LCA, 60% of AR CRD, 90% of AR CD, 
and 20% of ACHM remain to be identified. For several genes, only one 
or a few families with mutations have been reported; in these cases, 
the gene frequency was estimated to be 1%. Estimates are based on 
literature searches (http://www.sph.uth.tmc.edu/Retnet/home.htm) and 
our own experience.
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Finally, nontraditional animal models have been identified 
that provide additional interesting data with respect to disease 


























































































Approaches for surgical delivery of gene therapy vectors in retinal disease. Subretinal injec-
tion is necessary to place the gene augmentation therapy reagent in contact with the target 
photoreceptor and RPE cells. Arrows indicate the approaches used in the postnatal/adult 
mouse (A), large animals/humans (B), and fetal mice (C; injection into the subretinal space 
adjacent to retinal progenitor cells). (D–G) Frames from an intraoperative video taken during 
subretinal injection of the macula in a human with rAAV2.hRPE65v2 (64). In G, the cannula 
is withdrawn, revealing the raised fovea (black arrowhead). *optic disc; white arrowheads 
indicate edge of the expanding detachment.
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receptor guanylate cyclase gene causes the retinal 
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